In Poznań, laboratory research resulted in developing a method for extracting compounds from cannabis used as adjunctive therapy in cancer patients.
The University has conducted this project for four years in cooperation with a large group of partners, including the Institute of Natural Fibers and Medicinal Plants, Poznań University of Medical Sciences, Institute of Human Genetics — Polish Academy of Sciences in Poznań and PozLab.
The objective of the project is to develop an innovative technology for the extraction of compounds from cannabis with a low content of psychoactive substances to be used as adjunctive therapy in cancer patients. According to the results, chemical compounds (referred to as cannabinoids) contained in cannabis may shrink or even destroy cancer cells.
The Project Manager, Ryszard Słomski, Ph.D., professor at the Department of Biochemistry and Biotechnology, emphasizes the need for continued research because of encouraging results shown by strong anticancer properties of a whole range of compounds derived from cannabis. However, analyses, clinical trials and observations must be carried out for many years before the drug can be marketed.
May the scientists continue their successful work, access financial support and achieve satisfactory project outcomes.